Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial.
Takazono T, Hosogaya N, Fukushima K, Morio R, Irifune S, Miyamura T, Harada Y, Nagayoshi Y, Kondo A, Mihara T, Fukuda Y, Sasaki E, Sawai T, Imamura Y, Morikawa T, Futsuki Y, Inoue Y, Fukushima K, Suyama N, Tanaka H, Hanaka T, Shimabukuro I, Hata R, Ota K, Morimoto S, Nakada N, Ito Y, Yoshida M, Takeda K, Ide S, Iwanaga N, Nemoto K, Funada M, Izumikawa K, Yatera K, Yanagihara K, Mukae H.
Takazono T, et al. Among authors: fukushima k.
J Infect Chemother. 2024 Jul;30(7):597-602. doi: 10.1016/j.jiac.2024.01.003. Epub 2024 Jan 6.
J Infect Chemother. 2024.
PMID: 38190963
Free article.
Clinical Trial.